Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SHC +5%, FRPT +2.3%, BCRX +1.7%, TSN +1.7%, THS +1.2%
Other news:
- K +19.9% (Mars mulling acquisition of Kellanova (K))
- ZVRA +16.5% (reports FDA Advisory Committee votes favorably that the data support Arimoclomol as effective treatment for patients with Niemann-Pick Disease Type C)
- DOV +2.6% (increases quarterly cash dividend to $0.515/share from $0.51/share)
- OCGN +1.2% (announces FDA approval of expanded access program for patients with retinitis pigmentosa)
- TWKS +1.2% (to be taken private by Apax Funds for $4.40/share, also reported earnings)
Analyst comments:
- LMT +1.5% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
- CE +1.1% (upgraded to Neutral from Underweight at JP Morgan)